The New Report Collection Platform

Eliminates Information Barriers and Empowers Your Business Decisions!

 

If there are more needs or suggestions

Please contact us

E-mail:sales@bossonresearch.com

Global Pharmaceutical Aseptic Fill - Finish CMO Market Research Report 2022 (Status and Outlook)

Report Overview:

 

In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and doing.

The adoption of single-use or single-use equipment is the overarching trend in filling services. The use of aseptic kits in final filling services including single-use techniques can significantly reduce the risk of cross-contamination and reduce cleaning requirements. The use of facilities geared toward multi-product usage is one of the current trends across the industry. Additionally, manufacturers are actively developing fully automated, state-of-the-art filling-finishing packages to reduce the risks associated with operator involvement.

The global Pharmaceutical Aseptic Fill & Finish CMO market size is projected to reach US$ 6822.33 Million by 2029 from US$ 4936.96 million in 2022 at a CAGR of 5.97% during 2023-2029. Rising demand to reduce overall investment in drug development, filling Technological advancements in packing operation processes and increasing demand for outsourcing of fill-finish services will be the core drivers driving the growth of the Pharmaceutical Aseptic Fill & Finish CMO market.

The accuracy and success rate of drug filling plays an important role in reducing the overall cost of drug development. Some active pharmaceutical ingredients have strong efficacy and high cost, and the handling and filling of pharmaceutical powders such as active pharmaceutical ingredients in clinical development must be cautious. At the same time, the filling of biological products is an important link in the production process. Its production process is very complicated and unstable, so it is not suitable for terminal sterilization, and it needs to be sterilized during filter filling.

While traditional stainless steel systems require additional cleaning and sterilization (CP/SP) in traditional aseptic filling processes, single-use systems eliminate the critical sterilization step and further shorten the time by simplifying end-of-batch breakdown Changeover times and purge operations. Many pharmaceutical, biopharmaceutical and contract manufacturing organizations are adopting single-use fill-finish systems, especially for biologics. Technological advancements in aseptic fill operations involve the use of isolators and restricted access barrier systems (RABS), which create robust aseptic manufacturing environments that effectively separate operators from the fill completion process. Disposable systems also offer economic advantages, such as significantly less installation and clean-up time, which reduces labor costs. Single-use systems also help reduce capital costs and chemicals used while minimizing utilities and water. The increasing pace of technological advancements in the filling-finishing manufacturing process is actively driving the market growth.

Due to complex production and limited resources, it is common for the entire pharmaceutical industry to partner with CDMOs. The CDMO assists in the development and manufacture of aseptically filled finished products. Companies often consider outsourcing the filling and finishing of biopharmaceuticals to a CMO for production capacity or specialized manufacturing capabilities. The growing popularity of contract manufacturing organizations (CMOs) among various biotechnology companies is also considered to be a significant factor driving the market growth.

In addition, the growing demand for Pharmaceutical Aseptic Fill & Finish CMO in emerging markets will also become an important reason for the expansion of the entire Pharmaceutical Aseptic Fill & Finish CMO market. Emerging markets such as India and China will provide lucrative opportunities for the players in this market. At the same time, the COVID-19 pandemic has spurred the development of COVID-19 vaccines, antibody therapies, antiviral drugs, and various other related pharmaceutical products. The pandemic has severely affected countries such as Brazil, India, the United States, and major European countries, increasing the demand for biopharmaceutical products, thereby boosting pharmaceutical production. Vaccines and biologics require special manufacturing and filling equipment and procedures to ensure product quality and safety, which requires advanced analytical capabilities and adaptable aseptic filling techniques. This has also become the driving force for market development.

Segment by Type, the Pharmaceutical Aseptic Fill & Finish CMO can be split into Glass Vials, Disposable Syringes, etc. Glass Vials type occupies the highest market share, reaching 39.66% in 2021. Most biological products and vaccines are packed in glass vials to ensure extreme safety and avoid leakage. The Prefilled Syringes market is expected to register the fastest CAGR of 7.32% during the forecast period. Prefilled syringes are a well-established drug delivery technology for novel complex biologics and traditional small molecule drugs. They offer several advantages over other container types, such as reduced medication errors, fast and safe dosing and preparation, longer storage times, and lower risk of spillage, all of which contribute to development costs and reduced batch sizes . Hence, the segment is poised to witness considerable growth throughout the forecast period owing to the aforementioned factors.

According to application scenarios, pharmaceutical aseptic filling can be divided into vaccines, biological products and biosimilars, generic drugs and other sectors. In 2021, the vaccine segment has the highest market share, already reaching 38.85%, and will maintain this position during the forecast period. In addition, the market size of Biologics and Biosimilar and Generics will maintain a compound growth rate of more than 6.5%.

On basis of geography, the Pharmaceutical Aseptic Fill & Finish CMO market is segmented into North America, Europe, Asia-Pacific, South America, Middle East and Africa, etc. Asia-Pacific is the most important market for Pharmaceutical Aseptic Fill & Finish CMO, and in In 2021, it has already occupied more than 40% of the market share. During the forecast period, the Asia-Pacific market will continue to expand at the highest CAGR of 8.11%. This is mainly attributed to low labor and raw material costs, increasing research activities, favorable government support, and technological integration and advancement. Meanwhile, increasing number of CMOs expanding in the region and numerous bottling facilities under construction are also driving the market expansion. For example, Thermo Fisher will increase its aseptic filling capabilities with a new facility in Singapore. The facility will then initially provide a high-speed sterilization line approved for live viruses, which must first be filled with large-scale expertise in Singapore, before providing the additional capability of standard filling/finishing.

Currently, the concentration in the Pharmaceutical Aseptic Fill & Finish CMO market is low. According to our calculations, the two concentration indicators CR5 and HHI used to measure the market are 50.74% and 6.71% respectively, showing a relatively low level of concentration in 2022. In 2023, we expect the market concentration to decrease. More than 130 companies are actively providing aseptic fill/seal services for small molecules. Recently, many of the service providers mentioned above have also formed strategic alliances and/or acquired other players to further enhance their respective service offerings. This trend is also likely to continue for the foreseeable future. Key players in the market include Baxter Pharmaceutical Solutions LLC, Fresenius Kabi, Pfizer CentreOne, AbbVie, Vetter Pharma, Jubilant HollisterStier LLC, Ajinomoto Bio-Pharma Services, GRAM (Grand River Aseptic Manufacturing), Boehringer Ingelheim, WuXi Services, PCI, Pharma Aenova, TAIYO Pharma Tech Co.,Ltd., CMIC HOLDINGS Co., Ltd., Emergent BioSolutions, Bushu Pharmaceuticals, Novasep, HALIX, Symbiosis Pharmaceutical Services, Afton Scientific, Jiangsu Yaohai Bio-Pharmaceutical, Seikagaku, Techdow, Akron Biotech.

This report provides a deep insight into the global Pharmaceutical Aseptic Fill & Finish CMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps reader to shape the competition within the industries and strategies for the competitive environment in order to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Aseptic Fill & Finish CMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Aseptic Fill & Finish CMO market in any manner.

Global Pharmaceutical Aseptic Fill & Finish CMO Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Baxter Pharmaceutical Solutions LLC

Fresenius Kabi

Pfizer CentreOne

AbbVie

Vetter Pharma

Jubilant HollisterStier LLC 

Ajinomoto Bio-Pharma Services

GRAM (Grand River Aseptic Manufacturing)

Boehringer Ingelheim

WuXi Biologics

PCI Pharma Services

Aenova

TAIYO Pharma Tech Co.,Ltd.

CMIC HOLDINGS Co., Ltd.

Emergent BioSolutions

Bushu Pharmaceuticals

Novasep

HALIX

Symbiosis Pharmaceutical Services

Afton Scientific

Jiangsu Yaohai Bio-Pharmaceutical

Seikagaku

Techdow

Akron Biotech

 

Market Segmentation (by Type)

Glass Vials

Disposable Syringes

Prefilled Syringes

Filling

Others

Market Segmentation (by Application)

Vaccines

Biologics and Biosimilar

Generics

Other

Geographic Segmentation

 North America (USA, Canada, Mexico)

 Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

 Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

 South America (Brazil, Argentina, Columbia, Rest of South America)

 The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

 

Key Benefits of This Market Research:

 Industry drivers, restraints, and opportunities covered in the study

 Neutral perspective on the market performance

 Recent industry trends and developments

 Competitive landscape & strategies of key players

 Potential & niche segments and regions exhibiting promising growth covered

 Historical, current, and projected market size, in terms of value

 In-depth analysis of the Pharmaceutical Aseptic Fill & Finish CMO Market

 Overview of the regional outlook of the Pharmaceutical Aseptic Fill & Finish CMO Market:

 

Key Reasons to Buy this Report:

 Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

 This enables you to anticipate market changes to remain ahead of your competitors

 You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

 The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

 Provision of market value (USD Billion) data for each segment and sub-segment

 Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

 Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

 Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

 Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

 The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

 Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

 Provides insight into the market through Value Chain

 Market dynamics scenario, along with growth opportunities of the market in the years to come

 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

 

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

 

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Aseptic Fill & Finish CMO Market and its likely evolution in the short to mid-term, and long term.

 

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

 

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

 

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

 

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

 

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

 

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

 

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

 

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

 

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

 

Chapter 12 is the main points and conclusions of the report.

 

Table of Contents

1 Research Methodology and Statistical Scope        

1.1 Market Definition and Statistical Scope of Pharmaceutical Aseptic Fill & Finish CMO        

1.2 Key Market Segments        

1.2.1 Pharmaceutical Aseptic Fill & Finish CMO Segment by Type        

1.2.2 Pharmaceutical Aseptic Fill & Finish CMO Segment by Application        

1.3 Methodology & Sources of Information        

1.3.1 Research Methodology        

1.3.2 Research Process        

1.3.3 Market Breakdown and Data Triangulation        

1.3.4 Base Year        

1.3.5 Report Assumptions & Caveats        

2 Pharmaceutical Aseptic Fill & Finish CMO Market Overview        

2.1 Global Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) Estimates and Forecasts (2018-2029)        

2.2 Market Segment Executive Summary        

2.3 Global Market Size by Region        

3 Pharmaceutical Aseptic Fill & Finish CMO Market Competitive Landscape        

3.1 Global Pharmaceutical Aseptic Fill & Finish CMO Sales by Manufacturers (2018-2023)        

3.2 Global Pharmaceutical Aseptic Fill & Finish CMO Revenue Market Share by Manufacturers (2018-2023)        

3.3 Pharmaceutical Aseptic Fill & Finish CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)        

3.4 Global Pharmaceutical Aseptic Fill & Finish CMO Average Price by Manufacturers (2018-2023)        

3.5 Manufacturers Pharmaceutical Aseptic Fill & Finish CMO Sales Sites, Area Served, Product Type        

3.6 Pharmaceutical Aseptic Fill & Finish CMO Market Competitive Situation and Trends        

3.6.1 Pharmaceutical Aseptic Fill & Finish CMO Market Concentration Rate        

3.6.2 Global 5 and 10 Largest Pharmaceutical Aseptic Fill & Finish CMO Players Market Share by Revenue        

4 Pharmaceutical Aseptic Fill & Finish CMO Industry Chain Analysis        

4.1 Pharmaceutical Aseptic Fill & Finish CMO Industry Chain Analysis        

4.2 Market Overview of Key Raw Materials        

4.3 Midstream Market Analysis        

4.4 Downstream Customer Analysis        

5 The Development and Dynamics of Pharmaceutical Aseptic Fill & Finish CMO Market        

5.1 Key Development Trends        

5.2 Driving Factors        

5.3 Market Challenges        

5.4 Impact of COVID-19        

5.4.1 Epidemic Situation        

5.4.2 Impact Analysis of the Epidemic        

5.5 Industry News        

5.5.1 Mergers & Acquisitions        

5.5.2 Expansions        

5.5.3 Collaboration/Supply Contracts        

5.6 Industry Policies        

6 Pharmaceutical Aseptic Fill & Finish CMO Market Segmentation by Type        

6.1 Evaluation Matrix of Segment Market Development Potential (Type)        

6.2 Global Pharmaceutical Aseptic Fill & Finish CMO Market Size Market Share by Type (2018-2023)        

6.3 Global Pharmaceutical Aseptic Fill & Finish CMO Market Size Growth Rate by Type (2019-2023)        

7 Pharmaceutical Aseptic Fill & Finish CMO Market Segmentation by Application        

7.1 Evaluation Matrix of Segment Market Development Potential (Application)        

7.2 Global Pharmaceutical Aseptic Fill & Finish CMO Market Sales by Application (2018-2023)        

7.3 Global Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) by Application (2018-2023)        

7.4 Global Pharmaceutical Aseptic Fill & Finish CMO Sales Growth Rate by Application (2019-2023)        

8 Pharmaceutical Aseptic Fill & Finish CMO Market Segmentation by Region        

8.1 Global Pharmaceutical Aseptic Fill & Finish CMO Sales by Region        

8.1.1 Global Pharmaceutical Aseptic Fill & Finish CMO Sales by Region        

8.1.2 Global Pharmaceutical Aseptic Fill & Finish CMO Sales Market Share by Region        

8.2 North America        

8.2.1 North America Pharmaceutical Aseptic Fill & Finish CMO Sales by Country        

8.2.2 U.S.        

8.2.3 Canada        

8.2.4 Mexico        

8.3 Europe        

8.3.1 Europe Pharmaceutical Aseptic Fill & Finish CMO Sales by Country        

8.3.2 Germany        

8.3.3 France        

8.3.4 U.K.        

8.3.5 Italy        

8.3.6 Russia        

8.4 Asia Pacific        

8.4.1 Asia Pacific Pharmaceutical Aseptic Fill & Finish CMO Sales by Region        

8.4.2 China        

8.4.3 Japan        

8.4.4 South Korea        

8.4.5 India        

8.4.6 Southeast Asia        

8.5 South America        

8.5.1 South America Pharmaceutical Aseptic Fill & Finish CMO Sales by Country        

8.5.2 Brazil        

8.5.3 Argentina        

8.5.4 Columbia        

8.6 Middle East and Africa        

8.6.1 Middle East and Africa Pharmaceutical Aseptic Fill & Finish CMO Sales by Region        

8.6.2 Saudi Arabia        

8.6.3 UAE        

8.6.4 Egypt        

8.6.5 Nigeria        

8.6.6 South Africa        

9 Key Companies Profile        

9.1 Baxter Pharmaceutical Solutions LLC        

9.1.1 Baxter Pharmaceutical Solutions LLC Basic Information        

9.1.2 Baxter Pharmaceutical Solutions LLC Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.1.3 Baxter Pharmaceutical Solutions LLC Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.1.4 Baxter Pharmaceutical Solutions LLC Business Overview        

9.1.5 Baxter Pharmaceutical Solutions LLC SWOT Analysis        

9.1.6 Baxter Pharmaceutical Solutions LLC Recent Developments        

9.2 Fresenius Kabi        

9.2.1 Fresenius Kabi Basic Information        

9.2.2 Fresenius Kabi Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.2.3 Fresenius Kabi Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.2.4 Fresenius Kabi Business Overview        

9.2.5 Fresenius Kabi SWOT Analysis        

9.2.6 Fresenius Kabi Recent Developments        

9.3 Pfizer CentreOne        

9.3.1 Pfizer CentreOne Basic Information        

9.3.2 Pfizer CentreOne Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.3.3 Pfizer CentreOne Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.3.4 Pfizer CentreOne Business Overview        

9.3.5 Pfizer CentreOne SWOT Analysis        

9.3.6 Pfizer CentreOne Recent Developments        

9.4 AbbVie        

9.4.1 AbbVie Basic Information        

9.4.2 AbbVie Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.4.3 AbbVie Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.4.4 AbbVie Business Overview        

9.4.5 AbbVie Recent Developments        

9.5 Vetter Pharma        

9.5.1 Vetter Pharma Basic Information        

9.5.2 Vetter Pharma Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.5.3 Vetter Pharma Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.5.4 Vetter Pharma Business Overview        

9.5.5 Vetter Pharma Recent Developments        

9.6 Jubilant HollisterStier LLC        

9.6.1 Jubilant HollisterStier LLC Basic Information        

9.6.2 Jubilant HollisterStier LLC Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.6.3 Jubilant HollisterStier LLC Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.6.4 Jubilant HollisterStier LLC Business Overview        

9.6.5 Jubilant HollisterStier LLC Recent Developments        

9.7 Ajinomoto Bio-Pharma Services        

9.7.1 Ajinomoto Bio-Pharma Services Basic Information        

9.7.2 Ajinomoto Bio-Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.7.3 Ajinomoto Bio-Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.7.4 Ajinomoto Bio-Pharma Services Recent Developments        

9.8 GRAM (Grand River Aseptic Manufacturing)        

9.8.1 GRAM (Grand River Aseptic Manufacturing) Basic Information        

9.8.2 GRAM (Grand River Aseptic Manufacturing) Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.8.3 GRAM (Grand River Aseptic Manufacturing) Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.8.4 GRAM (Grand River Aseptic Manufacturing) Business Overview        

9.8.5 GRAM (Grand River Aseptic Manufacturing) Recent Developments        

9.9 Boehringer Ingelheim        

9.9.1 Boehringer Ingelheim Basic Information        

9.9.2 Boehringer Ingelheim Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.9.3 Boehringer Ingelheim Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.9.4 Boehringer Ingelheim Business Overview        

9.9.5 Boehringer Ingelheim Recent Developments        

9.10 WuXi Biologics        

9.10.1 WuXi Biologics Basic Information        

9.10.2 WuXi Biologics Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.10.3 WuXi Biologics Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.10.4 WuXi Biologics Business Overview        

9.10.5 WuXi Biologics Recent Developments        

9.11 PCI Pharma Services        

9.11.1 PCI Pharma Services Basic Information        

9.11.2 PCI Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.11.3 PCI Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.11.4 PCI Pharma Services Business Overview        

9.11.5 PCI Pharma Services Recent Developments        

9.12 Aenova        

9.12.1 Aenova Basic Information        

9.12.2 Aenova Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.12.3 Aenova Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.12.4 Aenova Business Overview        

9.12.5 Aenova Recent Developments        

9.13 TAIYO Pharma Tech Co.,Ltd.        

9.13.1 TAIYO Pharma Tech Co.,Ltd. Basic Information        

9.13.2 TAIYO Pharma Tech Co.,Ltd. Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.13.3 TAIYO Pharma Tech Co.,Ltd. Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.13.4 TAIYO Pharma Tech Co.,Ltd. Business Overview        

9.13.5 TAIYO Pharma Tech Co.,Ltd. Recent Developments        

9.14 CMIC HOLDINGS Co., Ltd.        

9.14.1 CMIC HOLDINGS Co., Ltd. Basic Information        

9.14.2 CMIC HOLDINGS Co., Ltd. Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.14.3 CMIC HOLDINGS Co., Ltd. Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.14.4 CMIC HOLDINGS Co., Ltd. Business Overview        

9.14.5 CMIC HOLDINGS Co., Ltd. Recent Developments        

9.15 Emergent BioSolutions        

9.15.1 Emergent BioSolutions Basic Information        

9.15.2 Emergent BioSolutions Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.15.3 Emergent BioSolutions Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.15.4 Emergent BioSolutions Business Overview        

9.15.5 Emergent BioSolutions Recent Developments        

9.16 Bushu Pharmaceuticals        

9.16.1 Bushu Pharmaceuticals Basic Information        

9.16.2 Bushu Pharmaceuticals Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.16.3 Bushu Pharmaceuticals Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.16.4 Bushu Pharmaceuticals Business Overview        

9.16.5 Bushu Pharmaceuticals Recent Developments        

9.17 Novasep        

9.17.1 Novasep Basic Information        

9.17.2 Novasep Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.17.3 Novasep Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.17.4 Novasep Business Overview        

9.17.5 Novasep Recent Developments        

9.18 HALIX        

9.18.1 HALIX Basic Information        

9.18.2 HALIX Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.18.3 HALIX Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.18.4 HALIX Business Overview        

9.18.5 HALIX Recent Developments        

9.19 Symbiosis Pharmaceutical Services        

9.19.1 Symbiosis Pharmaceutical Services Basic Information        

9.19.2 Symbiosis Pharmaceutical Services Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.19.3 Symbiosis Pharmaceutical Services Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.19.4 Symbiosis Pharmaceutical Services Business Overview        

9.19.5 Symbiosis Pharmaceutical Services Recent Developments        

9.20 Afton Scientific        

9.20.1 Afton Scientific Basic Information        

9.20.2 Afton Scientific Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.20.3 Afton Scientific Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.20.4 Afton Scientific Business Overview        

9.20.5 Afton Scientific Recent Developments        

9.21 Jiangsu Yaohai Bio-Pharmaceutical        

9.21.1 Jiangsu Yaohai Bio-Pharmaceutical Basic Information        

9.21.2 Jiangsu Yaohai Bio-Pharmaceutical Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.21.3 Jiangsu Yaohai Bio-Pharmaceutical Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.21.4 Jiangsu Yaohai Bio-Pharmaceutical Business Overview        

9.21.5 Jiangsu Yaohai Bio-Pharmaceutical Recent Developments        

9.22 Seikagaku        

9.22.1 Seikagaku Basic Information        

9.22.2 Seikagaku Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.22.3 Seikagaku Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.22.4 Seikagaku Business Overview        

9.22.5 Seikagaku Recent Developments        

9.23 Techdow        

9.23.1 Techdow Basic Information        

9.23.2 Techdow Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.23.3 Techdow Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.23.4 Techdow Business Overview        

9.23.5 Techdow Recent Developments        

9.24 Akron Biotech        

9.24.1 Akron Biotech Basic Information        

9.24.2 Akron Biotech Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

9.24.3 Akron Biotech Pharmaceutical Aseptic Fill & Finish CMO Product Market Performance        

9.24.4 Akron Biotech Business Overview        

9.24.5 Akron Biotech Recent Developments        

10 Pharmaceutical Aseptic Fill & Finish CMO Market Forecast by Region        

10.1 Global Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast        

10.2 Global Pharmaceutical Aseptic Fill & Finish CMO Market Forecast by Region        

10.2.1 North America Market Size Forecast by Country        

10.2.2 Europe Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Country        

10.2.3 Asia Pacific Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Region        

10.2.4 South America Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Country        

10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Aseptic Fill & Finish CMO by Country        

11 Forecast Market by Type and by Application (2024-2029)        

11.1 Global Pharmaceutical Aseptic Fill & Finish CMO Market Forecast by Type (2024-2029)        

11.1.1 Global Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Type (2024-2029)        

11.2 Global Pharmaceutical Aseptic Fill & Finish CMO Market Forecast by Application (2024-2029)        

11.2.1 Global Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units) Forecast by Application        

11.2.2 Global Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) Forecast by Application (2024-2029)        

12 Conclusion and Key Findings        

 

 

 

List of Tables

Table 1. Introduction of the Type        

Table 2. Introduction of the Application        

Table 3. Evaluation Matrix of Segment Market Size (M USD) Development Potential (Type)        

Table 4. Evaluation Matrix of Segment Market Size (M USD) Development Potential (Application)        

Table 5. Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) Comparison by Region (M USD)        

Table 6. Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) by Country        

Table 7. Global Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units) by Manufacturers (2018-2023)        

Table 8. Global Pharmaceutical Aseptic Fill & Finish CMO Sales Market Share by Manufacturers (2018-2023)        

Table 9. Global Pharmaceutical Aseptic Fill & Finish CMO Revenue (M USD) by Manufacturers (2018-2023)        

Table 10. Global Pharmaceutical Aseptic Fill & Finish CMO Revenue Share by Manufacturers (2018-2023)        

Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Aseptic Fill & Finish CMO as of 2022)        

Table 12. Global Market Pharmaceutical Aseptic Fill & Finish CMO Average Price (USD/K Units) of Key Manufacturers (2018-2023)        

Table 13. Manufacturers Pharmaceutical Aseptic Fill & Finish CMO Sales Sites and Area Served        

Table 14. Manufacturers Pharmaceutical Aseptic Fill & Finish CMO Product Type        

Table 15. Global Pharmaceutical Aseptic Fill & Finish CMO Manufacturers Market Concentration Ratio (CR5 and HHI)        

Table 16. Market Overview of Key Raw Materials        

Table 17. Midstream Market Analysis        

Table 18. Downstream Customer Analysis        

Table 19. Key Development Trends        

Table 20. Driving Factors        

Table 21. Pharmaceutical Aseptic Fill & Finish CMO Market Challenges        

Table 22. Mergers & Acquisitions        

Table 23. Expansions        

Table 24. Global Pharmaceutical Aseptic Fill & Finish CMO Market Size by Type (M USD)        

Table 25. Global Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) by Type (2018-2023)        

Table 26. Global Pharmaceutical Aseptic Fill & Finish CMO Market Size Share by Type (2018-2023)        

Table 27. Global Pharmaceutical Aseptic Fill & Finish CMO Market Size Growth Rate by Type (2019-2023)        

Table 28. Global Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units) by Application        

Table 29. Global Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) by Application        

Table 30. Global Pharmaceutical Aseptic Fill & Finish CMO Sales by Application (2018-2023) & (M Units)        

Table 31. Global Pharmaceutical Aseptic Fill & Finish CMO Sales Market Share by Application (2018-2023)        

Table 32. Global Pharmaceutical Aseptic Fill & Finish CMO Sales by Application (2018-2023) & (M USD)        

Table 33. Global Pharmaceutical Aseptic Fill & Finish CMO Market Share by Application (2018-2023)        

Table 34. Global Pharmaceutical Aseptic Fill & Finish CMO Sales Growth Rate by Application (2019-2023)        

Table 35. Global Pharmaceutical Aseptic Fill & Finish CMO Sales by Region (2018-2023) & (M Units)        

Table 36. Global Pharmaceutical Aseptic Fill & Finish CMO Sales Market Share by Region (2018-2023)        

Table 37. North America Pharmaceutical Aseptic Fill & Finish CMO Sales by Country (2018-2023) & (M Units)        

Table 38. Europe Pharmaceutical Aseptic Fill & Finish CMO Sales by Country (2018-2023) & (M Units)        

Table 39. Asia Pacific Pharmaceutical Aseptic Fill & Finish CMO Sales by Region (2018-2023) & (M Units)        

Table 40. South America Pharmaceutical Aseptic Fill & Finish CMO Sales by Country (2018-2023) & (M Units)        

Table 41. Middle East and Africa Pharmaceutical Aseptic Fill & Finish CMO Sales by Region (2018-2023) & (M Units)        

Table 42. Baxter Pharmaceutical Solutions LLC Basic Information        

Table 43. Baxter Pharmaceutical Solutions LLC Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 44. Baxter Pharmaceutical Solutions LLC Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 45. Baxter Pharmaceutical Solutions LLC SWOT Analysis        

Table 46. Fresenius Kabi Basic Information        

Table 47. Fresenius Kabi Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 48. Fresenius Kabi Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 49. Fresenius Kabi SWOT Analysis        

Table 50. Pfizer CentreOne Basic Information        

Table 51. Pfizer CentreOne Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 52. Pfizer CentreOne Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 53. Pfizer CentreOne SWOT Analysis        

Table 54. AbbVie Basic Information        

Table 55. AbbVie Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 56. AbbVie Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 57. Vetter Pharma Basic Information        

Table 58. Vetter Pharma Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 59. Vetter Pharma Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 60. Jubilant HollisterStier LLC Basic Information        

Table 61. Jubilant HollisterStier LLC Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 62. Jubilant HollisterStier LLC Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 63. Ajinomoto Bio-Pharma Services Basic Information        

Table 64. Ajinomoto Bio-Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 65. Ajinomoto Bio-Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 66. GRAM (Grand River Aseptic Manufacturing) Basic Information        

Table 67. GRAM (Grand River Aseptic Manufacturing) Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 68. GRAM (Grand River Aseptic Manufacturing) Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 69. Boehringer Ingelheim Basic Information        

Table 70. Boehringer Ingelheim Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 71. Boehringer Ingelheim Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 72. WuXi Biologics Basic Information        

Table 73. WuXi Biologics Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 74. WuXi Biologics Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 75. PCI Pharma Services Basic Information        

Table 76. PCI Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 77. PCI Pharma Services Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 78. Aenova Basic Information        

Table 79. Aenova Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 80. Aenova Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 81. TAIYO Pharma Tech Co.,Ltd. Basic Information        

Table 82. TAIYO Pharma Tech Co.,Ltd. Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 83. TAIYO Pharma Tech Co.,Ltd. Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 84. CMIC HOLDINGS Co., Ltd. Basic Information        

Table 85. CMIC HOLDINGS Co., Ltd. Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 86. CMIC HOLDINGS Co., Ltd. Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 87. Emergent BioSolutions Basic Information        

Table 88. Emergent BioSolutions Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 89. Emergent BioSolutions Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 90. Bushu Pharmaceuticals Basic Information        

Table 91. Bushu Pharmaceuticals Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 92. Bushu Pharmaceuticals Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 93. Novasep Basic Information        

Table 94. Novasep Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 95. Novasep Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 96. HALIX Basic Information        

Table 97. HALIX Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 98. HALIX Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 99. Symbiosis Pharmaceutical Services Basic Information        

Table 100. Symbiosis Pharmaceutical Services Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 101. Symbiosis Pharmaceutical Services Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 102. Afton Scientific Basic Information        

Table 103. Afton Scientific Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 104. Afton Scientific Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 105. Jiangsu Yaohai Bio-Pharmaceutical Basic Information        

Table 106. Jiangsu Yaohai Bio-Pharmaceutical Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 107. Jiangsu Yaohai Bio-Pharmaceutical Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 108. Seikagaku Basic Information        

Table 109. Seikagaku Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 110. Seikagaku Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 111. Techdow Basic Information        

Table 112. Techdow Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 113. Techdow Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 114. Akron Biotech Basic Information        

Table 115. Akron Biotech Pharmaceutical Aseptic Fill & Finish CMO Product Overview        

Table 116. Akron Biotech Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units), Revenue (M USD), Price (USD/K Units) and Gross Margin (2018-2023)        

Table 117. Global Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units) Forecast by Region (2024-2029)        

Table 118. Global Pharmaceutical Aseptic Fill & Finish CMO Market Size (M USD) Forecast by Region (2024-2029)        

Table 119. North America Pharmaceutical Aseptic Fill & Finish CMO Sales Forecast by Country (2024-2029) & (M Units)        

Table 120. North America Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Country (2024-2029) & (M USD)        

Table 121. Europe Pharmaceutical Aseptic Fill & Finish CMO Sales Forecast by Country (2024-2029) & (M Units)        

Table 122. Europe Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Country (2024-2029) & (M USD)        

Table 123. Asia Pacific Pharmaceutical Aseptic Fill & Finish CMO Sales Forecast by Region (2024-2029) & (M Units)        

Table 124. Asia Pacific Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Region (2024-2029) & (M USD)        

Table 125. South America Pharmaceutical Aseptic Fill & Finish CMO Sales Forecast by Country (2024-2029) & (M Units)        

Table 126. South America Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Country (2024-2029) & (M USD)        

Table 127. Middle East and Africa Pharmaceutical Aseptic Fill & Finish CMO Consumption Forecast by Country (2024-2029) & (M Units)        

Table 128. Middle East and Africa Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Country (2024-2029) & (M USD)        

Table 129. Global Pharmaceutical Aseptic Fill & Finish CMO Market Size Forecast by Type (2024-2029) & (M USD)        

Table 130. Global Pharmaceutical Aseptic Fill & Finish CMO Market Share Forecast by Type (2024-2029)        

Table 131. Global Pharmaceutical Aseptic Fill & Finish CMO Sales (M Units) Forecast by Application (2024-2029)        

Table 132. Global Pharmaceutical Aseptic Fill & Finish CMO Sales Forecast by Application (2024-2029)        

Custom Report
Created on:2023-03-13
Collect